OpenVSafe by OpenVAERS
Search V-safe

Y5C-12029-21330

3 vaccinations 2 coded responses 26 check-ins 2 free-text entries 4 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
194 / PA
Registered
2020-12-29
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Registered in v-safe
  2. 2020-12-29
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-29
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain, Itching · None
    Adult check-in
  4. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  5. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-01-05
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  10. 2021-01-15
    Dose 2 — Pfizer-BioNTech
  11. 2021-01-15
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  13. 2021-01-16
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  14. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-01-17
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  16. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  17. 2021-01-22
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-29
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-02-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-26
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-16
    Survey response — 3 months, dose 2
    MedDRA: Ageusia, Anosmia, Cough, Dyspnoea, Fatigue, Pain — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Fatigue, aches, loss of taste and smell, cough, shortness of breath
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-04-16
    Report sent to call center — 3 months, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-06-10
  26. 2021-07-16
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-09-13
    Dose 3 — Pfizer-BioNTech
  28. 2021-09-29
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  29. 2021-10-04
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  30. 2021-10-13
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-10-18
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-10-25
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-12-13
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  34. 2022-03-14
    Survey response — 6 months, dose 3
    MedDRA: Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Upper respiratory infection
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-03-14
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  36. 2022-03-15
  37. 2022-03-16
  38. 2022-03-17

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Pfizer-BioNTech
22021-01-15Pfizer-BioNTech
32021-09-13Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-01-16 priority 2/3
2021-01-17 priority 2/3
2021-04-16 Unsuccessful
2022-03-14 Unsuccessful

Free text

Release 7 — 3 months, dose 2

2021-04-16

Symptoms: Fatigue, aches, loss of taste and smell, cough, shortness of breath

Release 11 — 6 months, dose 3

2022-03-14

Symptoms: Upper respiratory infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia ✓ ✓ ✓
SDAnosmia ✓ ✓ ✓
SDCough ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDPain ✓ ✓ ✓
SDUpper respiratory tract infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…